中国僵尸片,亚洲欧美国产另类视频,亚洲精品无码人妻无码,亚洲有码转帖,亚洲欧美精品伊人久久,97精品依人久久久

400-885-9898
更新于 10月11日
智聯(lián)APPAPP
舉報

臨床項目管理總監(jiān)(J10520)

5-7萬
  • 北京朝陽區(qū)
  • 國貿(mào)
  • 5-10年
  • 本科
  • 全職
  • 招1人

職位描述

臨床試驗腫瘤科自免臨床項目管理總監(jiān)
崗位職責(zé):
1. Responsible for the management of clinical projects, including the initiation, monitoring, audit and regular data collection of clinical trials, timely discovery of problems, put forward questions and solutions, and ensure the quality and progress of the project。
2. Responsible for timely communication and coordination with relevant departments within the company in the process of project promotion; ensure that the team plans and delivers high-quality clinical trials in a timely manner, and is responsible for responsible team performance according to key indicators.
3. According to the needs of clinical projects, communicate with CRO companies, main investigators, clinical medical experts, and review experts to solve or assist in solving problems in the process of clinical research.
4. Develop a training plan for the clinical project manager team to improve project management skills and ensure high-quality delivery of clinical trial results.
5. Builds up clinical project managers team and manages resource according to trial needs, maintains a positive and results orientated work environment. Drives team members to improve their efficiency and effectiveness at prioritizing work and improving performance.
6. Ensures operational processes, systems and standards are adopted and implemented consistently across trials，Contributes to Clinical Operations and clinical trial sourcing strategy development and takes a lead role in cross-function governance.
7. Implements and revises SOPs and monitors team compliance. Participates in formal staff performance review processes. Communicates with internal and external staff effectively with a professional and collaborative approach.
8. Escalates issues to InnoCare Senior Management team timely, demonstrates strong initiative in activities through the clinical trials and other company initiatives, proactively identifies potential issues and seeks improvement.
任職要求:
1. At least 8 years of clinical study experience in pharmaceutical company or CRO, and more than 4 years of project management experience;
2. Familiar with the overall process of clinical study from the approval of the study until the end of the study, and fully understanding the coordination of all departments in each stage of clinical study;
3. Those with project experience in the field of autoimmune diseases and oncology will be preferred;
4. With good ability to communicate, manage and coordinate;
5. Proficiency in MS Office Suite, including Excel, Power Point, and Project;
6. Proficient in English as working language, good at reading and written English.

工作地點

朝陽區(qū)北京嘉里中心

職位發(fā)布者

婁女士/HR

昨日活躍
立即溝通
公司Logo諾誠健華
諾誠健華（上交所代碼：688428；香港聯(lián)交所代碼：09969）于2015年由世界著名結(jié)構(gòu)生物學(xué)家施一公院士和生物醫(yī)藥行業(yè)卓越的科學(xué)家兼企業(yè)家崔霽松博士聯(lián)合創(chuàng)立。作為一家植根于中國且具有全球視野的新藥創(chuàng)制公司，諾誠健華以“科學(xué)驅(qū)動創(chuàng)新患者所需為本”為價值理念，專注于惡性腫瘤和自身免疫性疾病的創(chuàng)新藥研究和開發(fā)。經(jīng)過近十年的堅實發(fā)展，公司在各方面取得重大進展。2020年3月23日，諾誠健華成功在港交所上市，成為2020年港交所生物醫(yī)藥第*一股。2022年9月21日，諾誠健華在上海證券交易所科創(chuàng)板上市，開啟了H+A的新征程。目前，諾誠健華已經(jīng)打造了具有市場前景的強大產(chǎn)品管線，覆蓋血液瘤、實體瘤和自身免疫性疾病。諾誠健華自主研發(fā)的國家“重大新藥創(chuàng)制”專項成果——BTK抑制劑奧布替尼（商品名：宜諾凱?）目前已在中國和新加坡獲批上市并納入中國國家醫(yī)保，是中國首*個且唯*一獲批針對邊緣區(qū)淋巴瘤的BTK抑制劑；坦昔妥單抗（商品名：明諾凱?）創(chuàng)新療法已成為中國首*個獲批治療復(fù)發(fā)/難治性彌漫性大B細胞淋巴瘤（R/R DLBCL）的CD19單抗；mesutoclax（ICP-248）是中國第*一個獲得突破性療法認定（Breakthrough Therapy Designation）的BCL2抑制劑，10多款創(chuàng)新藥在臨床階段。諾誠健華已經(jīng)構(gòu)建了從源頭創(chuàng)新、臨床開發(fā)、生產(chǎn)到商業(yè)化的全產(chǎn)業(yè)鏈平臺。在具有豐富研發(fā)、生產(chǎn)和商業(yè)化經(jīng)驗的管理團隊的帶領(lǐng)下，諾誠健華已構(gòu)建起一體化的生物醫(yī)藥平臺，包括藥物晶型研究平臺、難溶性藥物增溶制劑技術(shù)研發(fā)及產(chǎn)業(yè)化平臺、生物大分子發(fā)現(xiàn)和工程化改造平臺等，加速為全球腫瘤和自身免疫性疾病患者開發(fā)并提供極具市場前景的創(chuàng)新療法。發(fā)展至今，諾誠健華現(xiàn)有員工1200多人，眾多員工擁有海外工作和世界500*強藥企工作經(jīng)驗，并擁有多名國家*級、省市級人才專家。諾誠健華在北京、南京、上海、廣州、香港和美國等多地均設(shè)有分支機構(gòu)。
公司主頁